Point72 Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Point72 Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.2M	Sell	531,198 -2,472,913	-82%	-$144M	0.04%	570
2025 Q4	$162M	Buy	+3,004,111	New	+$145M	0.18%	89
2025 Q1	–	Sell	-1,410,278	Closed	-$82.2M	–	2060
2024 Q4	$79.8M	Sell	1,410,278 -1,470,027	-51%	-$82.1M	0.18%	132
2024 Q3	$149M	Buy	2,880,305 +2,242,312	+351%	+$105M	0.38%	35
2024 Q2	$26.5M	Buy	637,993 +444,106	+229%	+$19.9M	0.07%	336
2024 Q1	$10.5M	Buy	+193,887	New	+$9.88M	0.03%	699
2023 Q4	–	Sell	-765,327	Closed	-$40.2M	–	2198
2023 Q3	$44.4M	Buy	765,327 +756,964	+9,051%	+$46.4M	0.13%	200
2023 Q2	$535K	Buy	+8,363	New	+$561K	﹤0.01%	1251
2023 Q1	–	Sell	-499	Closed	-$35.2K	–	2244
2022 Q4	$35.9K	Buy	+499	New	+$37.6K	﹤0.01%	1353
2021 Q4	–	Sell	-665,200	Closed	-$39.4M	–	1099
2021 Q3	$39.4M	Buy	+665,200	New	+$43.8M	0.17%	146
2021 Q2	–	Sell	-259,100	Closed	-$16.4M	–	971
2021 Q1	$16.4M	Sell	259,100 -1,221,576	-83%	-$76M	0.08%	310
2020 Q4	$91.8M	Buy	1,480,676 +136,087	+10%	+$8.37M	0.45%	39
2020 Q3	$81.1M	Buy	1,344,589 +680,135	+102%	+$40.9M	0.42%	45
2020 Q2	$39.1M	Buy	664,454 +649,521	+4,350%	+$38.8M	0.25%	99
2020 Q1	$832K	Buy	+14,933	New	+$913K	0.01%	616
2019 Q3	–	Sell	-1,112,077	Closed	-$50.4M	–	1150
2019 Q2	$50.4M	Sell	1,112,077 -2,148,293	-66%	-$100M	0.26%	98
2019 Q1	$156M	Buy	3,260,370 +947,784	+41%	+$47.2M	0.71%	22
2018 Q4	$120M	Buy	2,312,586 +126,549	+6%	+$6.8M	0.59%	35
2018 Q3	$136M	Sell	2,186,037 -1,230,861	-36%	-$73M	0.56%	34
2018 Q2	$189M	Buy	3,416,898 +3,341,898	+4,456%	+$180M	0.75%	22
2018 Q1	$4.74M	Sell	75,000 -40,000	-35%	-$2.57M	0.02%	585
2017 Q4	$7.05M	Buy	115,000 +40,000	+53%	+$2.5M	0.03%	524
2017 Q3	$4.78M	Sell	75,000 -25,000	-25%	-$1.46M	0.02%	543
2017 Q2	$5.57M	Sell	100,000 -52,500	-34%	-$2.86M	0.03%	491
2017 Q1	$8.29M	Buy	+152,500	New	+$8.36M	0.05%	436
2016 Q3	–	Sell	-470,600	Closed	-$34.6M	–	713
2016 Q2	$34.6M	Sell	470,600 -61,500	-12%	-$4.35M	0.24%	112
2016 Q1	$34M	Sell	532,100 -732,100	-58%	-$46.2M	0.26%	105
2015 Q4	$87M	Buy	1,264,200 +165,200	+15%	+$10.9M	0.72%	24
2015 Q3	$65.1M	Buy	1,099,000 +249,800	+29%	+$15.8M	0.51%	40
2015 Q2	$56.5M	Buy	849,200 +228,300	+37%	+$15M	0.39%	58
2015 Q1	$40M	Buy	620,900 +374,500	+152%	+$23.4M	0.27%	98
2014 Q4	$14.5M	Buy	+246,400	New	+$13.9M	0.1%	265
2014 Q3	–	Sell	-3,900	Closed	-$189K	–	652
2014 Q2	$189K	Buy	+3,900	New	+$192K	﹤0.01%	676

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's BMY Position: Q1 2026 in Review

Point72 Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 82% in Q1 2026, selling an estimated $144M and leaving 531,198 shares worth $32.2M. The position accounts for 0.04% of the portfolio, ranked #570.

Point72 Asset Management first reported a position in BMY in Q2 2014 and has held it in 33 quarters since. The position peaked at $189M in Q2 2018. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Point72 Asset Management held 531,198 shares of Bristol-Myers Squibb worth $32.2M as of Q1 2026.
Point72 Asset Management sold 2,472,913 Bristol-Myers Squibb shares in Q1 2026, an estimated $144M.
Bristol-Myers Squibb made up 0.04% of Point72 Asset Management's portfolio in Q1 2026, its #570 holding.
Point72 Asset Management first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 33 quarters since.
Point72 Asset Management's Bristol-Myers Squibb position peaked at $189M in Q2 2018.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.